The Roadmap to Operationalizing AI & Digital Biomarkers in ALS Care
- Designing compliant, trustworthy AI in ALS: how companies balance regulatory rigor with rapid innovation in real world clinical and research settings
- Enabling hyper personalization through AI and digital biomarkers, using continuous, multimodal data to reflect individual disease trajectories rather than population averages
- Creating AI powered educational feedback loops that translate patient generated data into meaningful insights for patients, caregivers, and clinicians
- Leveraging tech enabled non profits as a deployment model, aligning patient trust, open collaboration, and mission driven AI innovation to accelerate impact in ALS